617 related articles for article (PubMed ID: 27116041)
1. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
Zhang K; Grima JC; Rothstein JD; Lloyd TE
Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
[TBL] [Abstract][Full Text] [Related]
2. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
[TBL] [Abstract][Full Text] [Related]
3. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
[TBL] [Abstract][Full Text] [Related]
4. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.
Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
6. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD.
Coyne AN; Rothstein JD
Acta Neuropathol Commun; 2021 Mar; 9(1):45. PubMed ID: 33741069
[TBL] [Abstract][Full Text] [Related]
7. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.
Jovičić A; Mertens J; Boeynaems S; Bogaert E; Chai N; Yamada SB; Paul JW; Sun S; Herdy JR; Bieri G; Kramer NJ; Gage FH; Van Den Bosch L; Robberecht W; Gitler AD
Nat Neurosci; 2015 Sep; 18(9):1226-9. PubMed ID: 26308983
[TBL] [Abstract][Full Text] [Related]
8. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.
Fallini C; Khalil B; Smith CL; Rossoll W
Neurobiol Dis; 2020 Jul; 140():104835. PubMed ID: 32179176
[TBL] [Abstract][Full Text] [Related]
9. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
Ortega JA; Daley EL; Kour S; Samani M; Tellez L; Smith HS; Hall EA; Esengul YT; Tsai YH; Gendron TF; Donnelly CJ; Siddique T; Savas JN; Pandey UB; Kiskinis E
Neuron; 2020 Apr; 106(1):90-107.e13. PubMed ID: 32059759
[TBL] [Abstract][Full Text] [Related]
10. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
11. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the impact of disrupted nucleocytoplasmic transport systems in
McGoldrick P; Robertson J
Front Cell Neurosci; 2023; 17():1247297. PubMed ID: 37720544
[TBL] [Abstract][Full Text] [Related]
13. Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granules.
McGoldrick P; Lau A; You Z; Durcan TM; Robertson J
Cell Rep; 2023 Mar; 42(3):112134. PubMed ID: 36821445
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
[TBL] [Abstract][Full Text] [Related]
15. LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient.
Lee J; Park J; Kim JH; Lee G; Park TE; Yoon KJ; Kim YK; Lim C
PLoS Biol; 2020 Dec; 18(12):e3001002. PubMed ID: 33362237
[TBL] [Abstract][Full Text] [Related]
16. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
17. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
18. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
19. Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells.
Shani T; Levy M; Israelson A
J Vis Exp; 2017 May; (123):. PubMed ID: 28570551
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Immune Activation by
Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
